Dualyx: Funding, Investors & Team (Sep 2026)
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Dualyx has raised $43.4M across 1 funding round on record, the most recent a Series A of $43.4M announced in May 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dualyx Company Profile and Key Stats
Latest funding round on record: May 2023.
Dualyx Funding Rounds
Dualyx Founders and Leadership Team
No contact details are on record for this team yet.
Dualyx Funding Compared to Other Biotechnology Startups
Dualyx's latest round of $43.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dualyx in Biotechnology and Ghent
Companies Similar to Dualyx
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells,…
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical…
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…
Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…
4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…
Tavira Therapeutics creates an innovative platform to improve the delivery of genes using AAV. By adding…
AgomAb is creating sub-atomic treatments for the recovery of harmed tissues. Their exceptional agonistic…
Dualyx Funding FAQs
What does Dualyx do?
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
How much funding has Dualyx raised?
Dualyx has raised $43.4M across 1 round on record. The most recent is a Series A of $43.4M announced in May 2023.
When did Dualyx last raise funding?
Dualyx's most recent funding round on record is a Series A of $43.4M, announced in May 2023.
Who founded Dualyx?
FundedIQ lists Luc Van Rompaey (Founder) at Dualyx.
Where is Dualyx headquartered?
Dualyx is based in Ghent, Oost-Vlaanderen, Belgium.
How many employees does Dualyx have?
Dualyx is in the 11-50 employee band.
How does Dualyx's funding compare to other Biotechnology startups?
Dualyx's latest round of $43.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Dualyx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dualyx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.